Veraxa Biotech AG - Post de-SPAC
Pharmaceutical company · Zurich, Switzerland · Nasdaq: VRXA
Veraxa Biotech AG - Post de-SPAC is a pharmaceutical company headquartered in Zurich, Switzerland. Its shares trade on Nasdaq under the ticker VRXA.
Profile compiled from public records. Is this your company? Request a correction or update
Veraxa Biotech AG - Post de-SPAC at a glance
Typepharmaceutical company
HeadquartersZurich, Switzerland
Stock listingNasdaq: VRXA
SEC industryPharmaceutical Preparations
SEC CIK2079109
Frequently asked questions about Veraxa Biotech AG - Post de-SPAC
Where is Veraxa Biotech AG - Post de-SPAC headquartered?
Veraxa Biotech AG - Post de-SPAC is headquartered in Zurich, Switzerland.
What does Veraxa Biotech AG - Post de-SPAC do?
Veraxa Biotech AG - Post de-SPAC is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Veraxa Biotech AG - Post de-SPAC a public company?
Yes. Veraxa Biotech AG - Post de-SPAC trades on Nasdaq under the ticker VRXA.
Similar companies
- NewcelX Ltd.Zürich, Zurich, Switzerland
- MindMaze Therapeutics Holding SAGeneva, Switzerland
- Novartis AgBasel, Basel-City, Switzerland
- BeOne Medicines Ltd.Basel, Basel-City, Switzerland
- Addex Therapeutics Ltd.Geneva, Switzerland
- MoonLake ImmunotherapeuticsZug, Switzerland
- Oculis Holding AGZug, Switzerland
- ADC Therapeutics SAEpalinges, Vaud, Switzerland
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences